Skip to content

Based on the real world acupuncture and moxibustion treatment of amphetamine-type drug protracted withdrawal syndrome evidence-based clinical program optimization and efficacy evaluation

Based on the real world acupuncture and moxibustion treatment of amphetamine-type drug protracted withdrawal syndrome evidence-based clinical program optimization and efficacy evaluation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040619
Enrollment
Unknown
Registered
2020-12-03
Start date
2021-05-01
Completion date
Unknown
Last updated
2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prolonged amphetamine-type drug withdrawal syndrome

Interventions

Sponsors

Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Conform to the diagnosis of ATS withdrawal symptoms; 2. Urine test for methamphetamine is negative; 3. Aged 18 to 60 years male and female, with clear consciousness, no aphasia or mental retardation, education level above elementary school, able to understand the content of the scale and cooperate with treatment; 4. Did not participate in other clinical trials within 3 months; 5. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with trauma or infection in the area receiving acupuncture; 2. Those who cannot tolerate acupuncture and electro-acupuncture or are allergic to acupuncture needles; 3. Women during pregnancy and lactation; 4. Severe heart, liver and kidney damage or suicidal tendency; 5. According to the judgment of the investigator, not suitable for patients participating in this study.

Design outcomes

Primary

MeasureTime frame
ACSA;

Secondary

MeasureTime frame
VAS;HAMD;HAMA;MoCA;PSQI;SF-36;

Countries

China

Contacts

Public ContactRen Yulan

Chengdu University of Traditional Chinese Medicine

renxg2468@qq.com+86 13689098226

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026